PNC FINANCIAL SERVICES GROUP, INC. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 98 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2018. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$5,060,491
-2.8%
327,116
-1.3%
0.00%0.0%
Q2 2023$5,204,152
-9.4%
331,264
-5.0%
0.00%
-20.0%
Q1 2023$5,745,517
+3.5%
348,636
-2.0%
0.01%0.0%
Q4 2022$5,549,242
+16.7%
355,721
-2.9%
0.01%0.0%
Q3 2022$4,755,000
-0.2%
366,507
+8.0%
0.01%0.0%
Q2 2022$4,763,000
-10.5%
339,221
-8.7%
0.01%0.0%
Q1 2022$5,319,000
-2.8%
371,396
-7.5%
0.01%0.0%
Q4 2021$5,475,000
-25.7%
401,711
-10.8%
0.01%
-28.6%
Q3 2021$7,373,000
-2.3%
450,114
+0.4%
0.01%0.0%
Q2 2021$7,543,000
-5.5%
448,146
+2.5%
0.01%
-12.5%
Q1 2021$7,985,000
-0.9%
437,259
-1.2%
0.01%0.0%
Q4 2020$8,057,000
+1.9%
442,711
-0.1%
0.01%
-20.0%
Q3 2020$7,907,000
-6.6%
443,150
-6.2%
0.01%
-9.1%
Q2 2020$8,470,000
+0.9%
472,308
-14.6%
0.01%0.0%
Q1 2020$8,397,000
-25.9%
553,176
-3.7%
0.01%0.0%
Q4 2019$11,329,000
+15.1%
574,260
+0.3%
0.01%
+10.0%
Q3 2019$9,843,000
-8.2%
572,311
-5.6%
0.01%
-9.1%
Q2 2019$10,727,000
-13.9%
606,036
-0.9%
0.01%
-8.3%
Q1 2019$12,453,000
+154.7%
611,355
+110.3%
0.01%
+140.0%
Q4 2018$4,889,000
+69742.9%
290,705
+91316.7%
0.01%
Q4 2014$7,0003180.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2018
NameSharesValueWeighting ↓
Glenview Capital Management 16,104,222$294,063,0004.98%
GMT CAPITAL CORP 2,468,695$45,078,0003.31%
MANAGED ASSET PORTFOLIOS, LLC 1,065,756$19,461,0003.13%
Blackcrane Capital, LLC 14,571$1,723,0002.72%
BFAM Partners (Cayman) Ltd 328,690$6,002,0002.36%
Paulson & Co. 4,727,415$86,323,0001.98%
Mondrian Investment Partners LTD 3,510,404$59,677,0001.28%
Lumbard & Kellner, LLC 135,550$2,264,0000.80%
DAVIDSON INVESTMENT ADVISORS 500,203$9,134,0000.78%
TFG Asset Management GP Ltd 589,390$10,762,0000.77%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders